BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Policy

  Sepracor, Inc.'s STEDESA(TM) (Eslicarbazepine Acetate) New Drug Application Formally Accepted for Review by the FDA

  June 1, 2009

   · 

  1 min read
• Policy

  ARCA biopharma Receives Complete Response Letter From FDA; FDA Does Not Approve GencaroTM NDA

  June 1, 2009

   · 

  5 min read
• Deals

  Elan Corporation PLC Shares Up as Bristol-Myers Squibb Company (JOBS) Eyes Stake

  June 1, 2009

   · 

  1 min read
• Deals

  Innovative Spinal Technologies Inc. Goes Bust

  June 1, 2009

   · 

  1 min read
• Drug Development

  Pfizer Inc. (JOBS) Discontinues Late-stage Trial of Sunitinib in Advanced Breast Cancer

  June 1, 2009

   · 

  5 min read
• Business

  MMS Holdings, Inc. Announces Addition of Scientific Board Member

  June 1, 2009

   · 

  1 min read
• Solasia: Sancuso(R) Clinical Trial Application Filed in China

  June 1, 2009

   · 

  1 min read
• Drug Development

  Exelixis, Inc. and Bristol-Myers Squibb Company (JOBS) Report Phase 2 Data for XL184 in Patients with Previously Treated Glioblastoma Multiforme; Results Not up Expectations

  June 1, 2009

   · 

  7 min read
• Business

  AstraZeneca PLC and Merck & Co., Inc. (JOBS) Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen

  June 1, 2009

   · 

  5 min read
• Drug Development

  Abraxis BioScience, Inc. Study Explores Potential Benefit of Nab(R)-Paclitaxel in Combination with Bevacizumab for the First-Line Treatment of Metastatic Breast Cancer

  June 1, 2009

   · 

  1 min read